Skip to main content
. 2021 Jun 8;116(6):1027–1036. [Article in Portuguese] doi: 10.36660/abc.20190158

Table 1. – Baseline characteristics of patients in each quartile of plasma NT-proBNP levels.

Characteristics All patients included NT-proBNP (pg/mL) p value

<124 124-271 271-668 ≥668
n 724 181 180 182 181  
Age(years) 86.6±3.0 85.7±2.9 86.1±2.9 87.0±2.9 87.4±3.0 <0.001
Male(%) 680(93.9) 171(94.5) 169(93.9) 168(92.3) 172(95.0) 0.727
Female(%) 44(6.1) 10(5.5) 11(6.1) 14(7.7) 9(5.0)
CHD(%) 589(81.4) 135(74.6) 144(80) 150(82.4) 160(88.4) 0.008
HT(%) 544(75.1) 124(68.5) 135(75) 144(79.1) 141(77.9) 0.088
DM(%) 298(41.2) 71(39.2) 69(38.3) 76(41.8) 82(45.3) 0.537
AF(%) 130(18.0) 15(8.3) 16(8.9) 27(14.8) 72(39.8) <0.001
BMI(kg/m2) 23.8±2.6 24.7±2.3 23.7±2.3 23.5±2.7 23.3±2.9 <0.001
NT-proBNP(pg/mL) 770±818 70±27 190±37 420±93 2399±1618 <0.001
eGFR(ml/min.1.73m2) 75.7±20.4 82.8±17.2 77.8±19.7 75.6±20.7 66.6±22.1 <0.001
sCr(ug/mL) 99.6±29.4 85.1±16.6 92.4±21.2 98.1±28.3 122.5±50.3 <0.001
BUN(mmol/L) 7.61±2.50 6.48±1.63 6.83±1.64 7.59±2.41 9.55±3.88 <0.001
TC(mmol/L) 4.14±0.67 4.31±0.67 4.24±0.65 4.00±0.69 3.99±0.61 <0.001
TG(mmol/L) 1.45±0.57 1.62±0.60 1.41±0.54 1.42±0.62 1.34±0.50 0.023
LDL-C(mmol/L) 2.37±0.57 2.54±0.59 2.46±0.57 2.23±0.57 2.26±0.52 <0.001
HDL-C(mmol/L) 1.16±0.23 1.13±0.24 1.18±0.25 1.18±0.27 1.16±0.29 0.473
Hb(g/L) 124.6±13.9 131.6±12.5 125.3±11.8 122.1±13.6 119.2±15.4 <0.001
ALB(g/L) 39±2.8 40.0±2.6 39.8±2.7 38.4±2.7 37.7±2.8 <0.001
LVEF(%) 60.0±3.8 61.4±3.1 60.8±2.9 59.7±4.2 57.9±4.4 <0.001
LVEF<40% 3 0 0 1 2  
LVEF>50% 697 180 179 173 165  
LVEDD(mm) 48.5±2.8 48.2±2.5 47.9±2.3 48.8±2.7 49.3±3.4 0.002
LVESD(mm) 32.9±2.3 32.2±1.7 32.3±2.0 33.2±2.4 34.0±2.9 <0.001
LAD(mm) 37.2±3.1 36.3±2.7 36.0±2.8 37.4±2.6 39.3±3.9 <0.001
IVS(mm) 10.7±1.1 10.6±1.0 10.5±1.0 10.7±1.2 10.9±1.2 0.040
PLVW(mm) 10.1±0.7 10.0±0.6 10.0±0.6 10.2±0.8 10.2±0.9 0.203
LVMI(g/m2) 123.2±19.9 118.9±15.7 118.0±16.0 126.7±19.4 129.1±27.5 <0.001
Anti-platelet drugs(%) 493(68.1) 118(65.2) 129(71.7) 120(65.9) 126(69.6) 0.506
Statins(%) 311(43.0) 84(46.4) 70(38.9) 78(42.9) 79(43.6) 0.547
CCB(%) 361(49.9) 95(52.5) 93(51.7) 87(47.8) 86(47.5) 0.697
ACEI(%) 92(12.7) 21(11.6) 25(13.9) 14(7.7) 32(17.7) 0.035
ARB(%) 227(31.4) 55(30.4) 62(34.4) 68(37.4) 42(23.2) 0.023
ACEI/ARB(%) 307(42.4) 72(39.8) 85(47.2) 79(43.4) 71(39.2) 0.386
Betablocker(%) 291(40.2) 58(32.0) 56(31.1) 82(45.1) 95(52.5) <0.001
Mean SBP(mmHg) 129.3±9.4 129.3±9.4 129.9±8.5 128.6±9.4 129.4±10.2 0.753
Mean DBP(mmHg) 67.3±5.8 68.2±5.7 68.1±5.2 66.9±5.9 66.2±6.1 0.027
MBP(mmHg) 88.0±6.0 88.6±6.2 88.7±5.2 87.5±5.9 87.3±6.4 0.152
PP(mmHg) 61.9±8.6 61.1±7.9 61.9±8.7 61.7±8.6 63.2±9.2 0.348

CHD: coronary heart disease; HT: hypertension; DM: diabetes mellitus; AF: atrial fibrillation; BMI: body mass index; NT-proBNP: N-terminal pro-brain natriuretic peptide; eGFR: estimated glomerular filtration rate; sCr: serum creatinine; BUN: blood urea nitrogen; UA: uric acid; TC: total cholesterols; TG: triglycerides; LDL-C: low density lipoprotein-cholesterol; HDL-C: high density lipoprotein-cholesterol; Hb: hemoglobin; ALB: plasma albumin; LVEF: left ventricular ejection fraction; LVEDD: left ventricular end-diastolic diameter; LVESD: left ventricular end-systolic diameter; LAD: left atrial diameter; IVS: interventricular septum; PLVM: posterior left ventricular wall; LVMI: left ventricular mass index; CCB: calcium channel blocker; ACEI: angiotensin converting enzyme inhibitor; ARB: angiotensin receptor antagonists; SBP: systolic blood pressure; DBP: diastolic blood pressure; MBP: mean blood pressure; PP: pulse pressure.